A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PGI-S / Patient Global Impression of Severity

[Related PubMed/MEDLINE]
Total Number of Papers: 50
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PGI-S  (>> Co-occurring Abbreviation)
Long Form:   Patient Global Impression of Severity
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2023 Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness. MSAQ, MSSS
2022 Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings. BYOD, CAT, COPD, E-RS, EXACT, ICCs, PD, PRO, TOSTs
2022 Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures. ICC, NSCLC, PGIC, PRO
2022 Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial. EQ VAS, HCM, HCMSQ, HCMSQ, LVOT, NYHA, PGIC, SOB
2022 Memory-Assisted Global Impression of Change (MAGIC). MAGIC, PD, PGIC
2022 Minimally Clinically Important Difference in Health Status Scores inPatients With HFrEF vs HFpEF. HFpEF, HFrEF, KCCQ, TSS
2022 Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments. BPI, CLOVES, CLVM, COAs, FAVA, HRQoL, KT, LM, MCAP or M-CM, PROMIS
2022 Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients. SE-C19
2021 Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures. AASDS, ADSD, ANSD
10  2021 Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary. AIM-D, CE, CM, EM, PDAs, PI, PRO
11  2021 Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open-label, phase 3, dose-titration study. CGIC, MCC, NDO, PINQ
12  2021 Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study. PGI-I, POP
13  2021 Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study. GSS, ISM, ISM-SAF, SSS, TSS
14  2021 Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine. CM, EF, EM, ePRO, MSQv2.1, RFP, RFR
15  2021 Randomized trial comparing efficacy of pelvic floor muscle training with a digital therapeutic motion-based device to standard pelvic floor exercises for treatment of stress urinary incontinence (SUV trial): An all-virtual trial design. AE, PFDI-20, PFIQ-7, PFMT, PGI-I, PISQ-IR, SUI
16  2021 The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine. BD, MCT, MDD, QIDS-SR16, TRD
17  2021 Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase2 Randomized Controlled Study. GMB, PGI-I, PSMQ-M
18  2021 Urge suppression and modified fluid consumption in the management of female overactive bladder symptoms. OAB, PGI-I
19  2020 Bladder diary characteristics and progress in patients with painful bladder syndrome. 3dBD, BPIC-SS, BPS, CI, EQ-5D-5L, UF
20  2020 Efficacy of urodynamic studies in predicting long-term outcomes of the transobturator tape: do they augment clinical assessment? ICIQ, ISC, PGI-I, PROMs, SUI, TOT
21  2020 Galcanezumab for the Management of Migraine: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. CGRP, MHDs, MIDAS, MSQ RF-R, URTI
22  2020 Mini-Slings: Do They Stand the Test of Time? A 10-Year Cohort. PGI-I, SUI
23  2020 Psychometric evaluation of the DAILY EATS questionnaire in individuals living with obesity. EDI, PRO
24  2020 Single-Incision Mini-Sling for the Treatment of Female Stress Urinary Incontinence: Is it Actually Inferior to Transobturator Vaginal Tape and Tension-Free Vaginal Tape? PGI-I, SIMS, SUI, TOT, TVT
25  2020 Use of the single-item Patient Global Impression-Severity scale as a self-reported assessment of insomnia severity. ISI
26  2020 Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies. AH, MP SAP-c v3, UF-DBD
27  2019 Domain Comparison Between 6 Validated Questionnaires Administered to Women With Urinary Incontinence. KHQ, QoL, SUI, UI, UUI
28  2019 Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine. CM, ePRO, MHD, MIDAS, MSQv2.1, PGI-I, RFR
29  2018 Efficacy of mace (Arils of Myristica fragrans Houtt) plus PFMT on symptoms in mixed urinary incontinence: a randomized placebo-controlled trial. HRQoL, IIQ-7, MUI, PFMT, PGI-I, UDI-6
30  2018 Independent validation of the Quality of Life in Essential Tremor Questionnaire (QUEST). QUEST
31  2017 Adult Onset Nocturnal Enuresis: Identifying Causes, Cofactors and Impact on Quality of Life. AUAss, HRQL, NE, NGB, OAB-q SF, OSA
32  2017 Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample. ACR, FM, PGI-B, PLA
33  2017 Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population. IBS-D, PGIC, SD
34  2016 [Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)]. NBD
35  2015 Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. AEs, FM, JFM, LTR, MASC
36  2014 Mini-arc for the treatment of female stress urinary incontinence: long-term prospective evaluation by patient reported outcomes. PGI-I, SUI
37  2014 Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. CGI-S, IVRS/IWRS, JRS, QoL
38  2014 Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. ABSST, MS, OAB, OAB-q SF, UUI
39  2014 [Efficacy of periurethral injections of polyacrylamide hydrogel (Bulkamid()) and quality of life of patients with urinary incontinence due to sphincter deficiency (IUE-IS)]. ICIQ-SF, IUE-IS, PGI-I, SUI
40  2013 Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. EMG, FSFI, PGI-I, VAS
41  2013 Single incision mid-urethral slings: impact of obesity on outcomes. BMI, PGI-I, SIS, W-IPSS
42  2012 Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. ANOVA, BII, BPH, IPSS, IPSS-QoL, LUTS
43  2011 Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy. DBS, TRS, UDRS, Vo
44  2011 [Success of treatment in higher stages of pain chronification as well? An evaluation of the Mainz pain staging system based on the QUAST-analysis sample]. MPSS
45  2010 Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes. AE, DBS, PD, QoL
46  2009 Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial. CGI-S, PaRTS-D, Q-LES-Q, SDS
47  2008 TVT-secur: a minimally invasive procedure for the treatment of primary stress urinary incontinence. One year data from a multi-centre prospective trial. PGI-I, QoL, W-IPSS
48  2007 Peri-operative morbidity and early results of a randomised trial comparing TVT and TVT-O. W-IPSS
49  2007 Transfascial vaginal tape (TFT): a simple, safe and cost-effective procedure for stress urinary incontinence. A preliminary study. I-QOL, TFT
50  2003 Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. I-QOL